Eight studies (29.6%) evaluated only BRCA1 and BRCA2 PV/LPV, three studies (11.1%) looked at Lynch syndrome genes MLH1, MSH2, MSH6, PMS2 and EPCAM PV/LPV, whereas 11 studies (40.7%) evaluated broader gene panels. This evidence concerns the gene PMS2 and Lynch syndrome.